{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:37:48Z","timestamp":1768347468832,"version":"3.49.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00296-022-05159-4","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T06:02:36Z","timestamp":1655359356000},"page":"1605-1615","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Assessment of serum and synovial fluid MMP-3 and MPO as biomarkers for psoriatic arthritis and their relation to disease activity indices"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7655-3846","authenticated-orcid":false,"given":"Mariela","family":"Geneva-Popova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5808-6586","authenticated-orcid":false,"given":"Stanislava","family":"Popova-Belova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5733-5520","authenticated-orcid":false,"given":"Velichka","family":"Popova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4636-1384","authenticated-orcid":false,"given":"Kostadin","family":"Chompalov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8857-0574","authenticated-orcid":false,"given":"Anastas","family":"Batalov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"issue":"3","key":"5159_CR1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s40744-019-0159-1","volume":"6","author":"J Belasco","year":"2019","unstructured":"Belasco J, Wei N (2019) Psoriatic arthritis: what is happening at the joint? Rheumatol Ther 6(3):305\u2013315","journal-title":"Rheumatol Ther"},{"issue":"4","key":"5159_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/RHU.0b013e318293eaeb","volume":"19","author":"TG Benedek","year":"2013","unstructured":"Benedek TG (2013) Psoriasis and psoriatic arthropathy, historical aspects: part I. J Clin Rheumatol 19(4):193\u2013198","journal-title":"J Clin Rheumatol"},{"issue":"5","key":"5159_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/RHU.0b013e31829d4ad4","volume":"19","author":"TG Benedek","year":"2013","unstructured":"Benedek TG (2013) Psoriasis and psoriatic arthropathy: historical aspects: part II. J Clin Rheumatol 19(5):267\u2013271","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"5159_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12016-012-8302-6","volume":"44","author":"V Dhir","year":"2013","unstructured":"Dhir V, Aggarwal A (2013) Psoriatic arthritis: a critical review. Clin Rev Allergy Immunol 44(2):141\u2013148","journal-title":"Clin Rev Allergy Immunol"},{"key":"5159_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-19530-8_14","volume-title":"Psoriatic Arthritis and Psoriasis","author":"B ShafaeddinSchreve","year":"2016","unstructured":"ShafaeddinSchreve B, Boehncke WH (2016) Psoriasis. In: Adebajo A, Boehncke WH, Gladman D, Mease P (eds) Psoriatic Arthritis and Psoriasis. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-319-19530-8_14"},{"issue":"5","key":"5159_CR6","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1111\/j.1365-2133.2008.09023.x","volume":"160","author":"K Reich","year":"2009","unstructured":"Reich K, Kr\u00fcger K, M\u00f6ssner R et al (2009) Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 160(5):1040\u20131047","journal-title":"Br J Dermatol"},{"issue":"7","key":"5159_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11926-018-0746-0","volume":"20","author":"O Elalouf","year":"2018","unstructured":"Elalouf O, Chandran V (2018) Novel therapeutics in psoriatic arthritis. What is in the pipeline? Curr Rheumatol Rep 20(7):36. https:\/\/doi.org\/10.1007\/s11926-018-0746-0","journal-title":"Curr Rheumatol Rep"},{"issue":"7","key":"5159_CR8","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/rheumatology\/keq105","volume":"49","author":"V Chandran","year":"2010","unstructured":"Chandran V, Cook RJ, Edwin J et al (2010) Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis. Rheumatology (Oxford) 49(7):1399\u20131405","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"5159_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/proteomes6010005","volume":"6","author":"SM Mahendran","year":"2018","unstructured":"Mahendran SM, Chandran V (2018) Exploring the psoriatic arthritis proteome in search of novel biomarkers. Proteomes 6(1):5. https:\/\/doi.org\/10.3390\/proteomes6010005","journal-title":"Proteomes"},{"issue":"2","key":"5159_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1602\/neurorx.1.2.182","volume":"1","author":"R Mayeux","year":"2004","unstructured":"Mayeux R (2004) Biomarkers: potential uses and limitations. NeuroRx 1(2):182\u2013188","journal-title":"NeuroRx"},{"issue":"9","key":"5159_CR11","doi-asserted-by":"publisher","first-page":"e12556","DOI":"10.1371\/journal.pone.0012556","volume":"5","author":"AW van Kuijk","year":"2010","unstructured":"van Kuijk AW, DeGroot J, Koeman RC et al (2010) Soluble biomarkers of cartilage and bone metabolism in early proof of concept trials in psoriatic arthritis: effects of adalimumab versus placebo. PLoS ONE 5(9):e12556. https:\/\/doi.org\/10.1371\/journal.pone.0012556","journal-title":"PLoS ONE"},{"issue":"31","key":"5159_CR12","doi-asserted-by":"publisher","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","volume":"274","author":"H Nagase","year":"1999","unstructured":"Nagase H, Woessner JF Jr (1999) Matrix metalloproteinases. J Biol Chem 274(31):21491\u201321494","journal-title":"J Biol Chem"},{"issue":"5","key":"5159_CR13","first-page":"585","volume":"140","author":"VV Ravi Kanth","year":"2014","unstructured":"Ravi Kanth VV, Nageshwar Reddy D (2014) Role of matrix metalloproteinases in physiological processes and disease. Indian J Med Res 140(5):585\u2013587","journal-title":"Indian J Med Res"},{"issue":"4","key":"5159_CR14","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/jnr.20986","volume":"84","author":"MC Falo","year":"2006","unstructured":"Falo MC, Fillmore HL, Reeves et al (2006) Matrix metalloproteinase-3 expression profile differentiates adaptive and maladaptive synaptic plasticity induced by traumatic brain injury. J Neurosci Res. 84(4):768\u201381","journal-title":"J Neurosci Res."},{"issue":"7","key":"5159_CR15","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1128\/MCB.01288-07","volume":"28","author":"T Eguchi","year":"2008","unstructured":"Eguchi T, Kubota S, Kawata K et al (2008) Novel transcription-factor-like function of human matrix metalloproteinase 3 regulating the CTGF\/CCN2 gene. Mol Cell Biol 28(7):2391\u20132413","journal-title":"Mol Cell Biol"},{"issue":"Pt 10","key":"5159_CR16","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1242\/jcs.02360","volume":"118","author":"WB Saunders","year":"2005","unstructured":"Saunders WB, Bayless KJ, Davis GE (2005) MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices. J Cell Sci 118(Pt 10):2325\u20132340","journal-title":"J Cell Sci"},{"issue":"2","key":"5159_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1136\/ard.61.2.161","volume":"61","author":"C Ribbens","year":"2002","unstructured":"Ribbens C, Martin Y, Porras M et al (2002) Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. Ann Rheum Dis 61(2):161\u2013166","journal-title":"Ann Rheum Dis"},{"issue":"6646","key":"5159_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/37995","volume":"389","author":"FX Gomis-R\u00fcth","year":"1997","unstructured":"Gomis-R\u00fcth FX, Maskos K, Betz M et al (1997) Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 389(6646):77\u201381","journal-title":"Nature"},{"key":"5159_CR19","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2741\/1817","volume":"11","author":"PS Burrage","year":"2006","unstructured":"Burrage PS, Mix KS, Brinckerhoff CE (2006) Matrix metalloproteinases: role in arthritis. Front Biosci 11:529\u2013543","journal-title":"Front Biosci"},{"key":"5159_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2022.100223","author":"M Zhang","year":"2022","unstructured":"Zhang M, Hu W, Cai C et al (2022) Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment. Mater Today Bio. https:\/\/doi.org\/10.1016\/j.mtbio.2022.100223","journal-title":"Mater Today Bio"},{"key":"5159_CR21","doi-asserted-by":"publisher","DOI":"10.1042\/bj3210503","author":"AJ Kettle","year":"1997","unstructured":"Kettle AJ, Gedye CA, Winterbourn CC (1997) Mechanism of inactivation of myeloperoxidase by 4-aminobenzoic acid hydrazide. Biochem J. https:\/\/doi.org\/10.1042\/bj3210503","journal-title":"Biochem J"},{"issue":"1","key":"5159_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3164\/jcbn.11-006FR","volume":"48","author":"MJ Davies","year":"2011","unstructured":"Davies MJ (2011) Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention. J Clin Biochem Nutr 48(1):8\u201319","journal-title":"J Clin Biochem Nutr"},{"issue":"11","key":"5159_CR23","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.jacc.2009.11.050","volume":"55","author":"CL Heslop","year":"2010","unstructured":"Heslop CL, Frohlich JJ, Hill JS (2010) Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography. J Am Coll Cardiol 55(11):1102\u20131109","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"5159_CR24","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/acr.23298","volume":"70","author":"D Cretu","year":"2018","unstructured":"Cretu D, Gao L, Liang K et al (2018) Differentiating psoriatic arthritis from psoriasis without psoriatic arthritis using novel serum biomarkers. Arthritis Care Res (Hoboken) 70(3):454\u2013461","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"5159_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3899\/jrheum.140223","volume":"42","author":"DR Jadon","year":"2015","unstructured":"Jadon DR, Nightingale AL, McHugh NJ et al (2015) Serum soluble bone turnover biomarkers in psoriatic arthritis and psoriatic spondyloarthropathy. J Rheumatol 42(1):21\u201330","journal-title":"J Rheumatol"},{"key":"5159_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1417-7","author":"DR Jadon","year":"2017","unstructured":"Jadon DR, Sengupta R, Nightingale A et al (2017) Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study. Arthritis Res Ther. https:\/\/doi.org\/10.1186\/s13075-017-1417-7","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"5159_CR27","doi-asserted-by":"publisher","first-page":"R148","DOI":"10.1186\/ar3090","volume":"12","author":"U Fiocco","year":"2010","unstructured":"Fiocco U, Sfriso P, Oliviero F et al (2010) Synovial effusion and synovial fluid biomarkers in psoriatic arthritis to assess intraarticular tumor necrosis factor-\u03b1 blockade in the knee joint. Arthritis Res Ther 12(4):R148","journal-title":"Arthritis Res Ther"},{"key":"5159_CR28","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120246","author":"U Fiocco","year":"2012","unstructured":"Fiocco U, Oliviero F, Sfriso P et al (2012) Synovial biomarkers in psoriatic arthritis. J Rheumatol Suppl. https:\/\/doi.org\/10.3899\/jrheum.120246","journal-title":"J Rheumatol Suppl"},{"issue":"10","key":"5159_CR29","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD (2017) Psoriatic arthritis. N Engl J Med 376(10):957\u2013970","journal-title":"N Engl J Med"},{"issue":"12","key":"5159_CR30","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/iub.1453","volume":"67","author":"SY Paek","year":"2015","unstructured":"Paek SY, Han L, Weiland M et al (2015) Emerging biomarkers in psoriatic arthritis. IUBMB Life 67(12):923\u2013927","journal-title":"IUBMB Life"},{"key":"5159_CR31","unstructured":"Zisman D, Saphieh M, Feld J, et al (2022) The Role of Extracellular Matrix Metalloproteinase Inducer Emmprin in\u00a0the Pathogenesis of Psoriatic Arthritis [abstract].\u00a0Arthritis Rheumatol.70 (suppl 10). https:\/\/acrabstracts.org\/abstract\/the-role-of-extracellular-matrix-metalloproteinase-inducer-emmprin-in-the-pathogenesis-of-psoriatic-arthritis\/. Accessed 22 Mar 2022."},{"issue":"6","key":"5159_CR32","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.5114\/ada.2020.94903","volume":"37","author":"M Waszczykowski","year":"2020","unstructured":"Waszczykowski M, Bednarski I, Narbutt J et al (2020) Interleukin-18, interleukin-20, and matrix metalloproteinases (MMP-1, MMP-3) as markers of psoriatic arthritis disease severity and their correlations with biomarkers of inflammation and turnover of joint cartilage. Postepy Dermatol Alergol 37(6):1001\u20131008","journal-title":"Postepy Dermatol Alergol"},{"issue":"3","key":"5159_CR33","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/1744666X.2020.1729129","volume":"16","author":"TA Boyd","year":"2020","unstructured":"Boyd TA, Eastman PS, Huynh DH et al (2020) Correlation of serum protein biomarkers with disease activity in psoriatic arthritis. Expert Rev Clin Immunol 16(3):335\u2013341","journal-title":"Expert Rev Clin Immunol"},{"issue":"8","key":"5159_CR34","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1080\/1744666X.2019.1627876","volume":"15","author":"MS Chimenti","year":"2019","unstructured":"Chimenti MS, Triggianese P, De Martino E et al (2019) An update on pathogenesis of psoriatic arthritis and potential therapeutic targets. Expert Rev Clin Immunol 15(8):823\u2013836","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"5159_CR35","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s12016-017-8630-7","volume":"55","author":"A McArdle","year":"2017","unstructured":"McArdle A, Pennington S, FitzGerald O (2017) Clinical features of psoriatic arthritis: a comprehensive review of unmet clinical needs. Clin Rev Allergy Immunol 55(3):271\u2013294","journal-title":"Clin Rev Allergy Immunol"},{"issue":"Suppl 2","key":"5159_CR36","doi-asserted-by":"publisher","first-page":"ii104","DOI":"10.1136\/annrheumdis-2012-203037","volume":"72","author":"F Villanova","year":"2012","unstructured":"Villanova F, Di Meglio P, Nestle FO (2012) Biomarkers in psoriasis and psoriatic arthritis. Ann Rheum Dis. 72(Suppl 2):ii104-110","journal-title":"Ann Rheum Dis."},{"issue":"6","key":"5159_CR37","doi-asserted-by":"publisher","first-page":"435","DOI":"10.5114\/ada.2016.63882","volume":"33","author":"N Dilek","year":"2016","unstructured":"Dilek N, Dilek AR, Ta\u015fk\u0131n Y et al (2016) Contribution of myeloperoxidase and inducible nitric oxide synthase to pathogenesis of psoriasis. Postepy Dermatol Alergol 33(6):435\u2013439","journal-title":"Postepy Dermatol Alergol"},{"issue":"4","key":"5159_CR38","first-page":"939","volume":"34","author":"S Popova","year":"2019","unstructured":"Popova S, Geneva-Popova M, Batalov A (2019) Serum level of MMP-3 in patients with psoriatic artritis treated with TNF-a blokers. Knowledge IJ. 2019. Med Sciences and health 34(4):939\u2013942","journal-title":"Med Sciences and health"},{"issue":"12","key":"5159_CR39","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/1346-8138.13968","volume":"44","author":"N Tsuruta","year":"2017","unstructured":"Tsuruta N, Imafuku S, Narisawa Y (2017) Hyperuricemia is an independent risk factor for psoriatic arthritis in psoriatic patients. J Dermatol 44(12):1349\u20131352","journal-title":"J Dermatol"},{"key":"5159_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.737573","volume":"8","author":"C Tripolino","year":"2021","unstructured":"Tripolino C, Ciaffi J, Ruscitti P, Giacomelli R, Meliconi R, Ursini F (2021) Hyperuricemia in psoriatic qrthritis: Epidemiology, pathophysiology, and clinical implications. Front Med (Lausanne) 8:737573","journal-title":"Front Med (Lausanne)"},{"issue":"Suppl 2","key":"5159_CR41","first-page":"ii3","volume":"64","author":"PS Helliwell","year":"2004","unstructured":"Helliwell PS, Taylor WJ (2004) Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis 64(Suppl 2):ii3-8","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"5159_CR42","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1007\/s11999-016-4732-4","volume":"474","author":"MD Kohn","year":"2016","unstructured":"Kohn MD, Sassoon AA, Fernando ND (2016) Classifications in brief: kellgren-lawrence classification of osteoarthritis. Clin Orthop Relat Res 474(8):1886\u20131893","journal-title":"Clin Orthop Relat Res"},{"issue":"8","key":"5159_CR43","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/art.1780290816","volume":"29","author":"R Altman","year":"1986","unstructured":"Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M et al (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and therapeutic criteria committee of the American rheumatism association. Arthritis Rheum 29(8):1039\u201349","journal-title":"Arthritis Rheum"},{"issue":"3","key":"5159_CR44","volume":"2","author":"DA Delgado","year":"2018","unstructured":"Delgado DA, Lambert BS, Boutris N, McCulloch PC, Robbins AB, Moreno MR, Harris JD (2018) Validation of digital visual analog scale pain scoring with a traditional paper-based visual analog scale in adults. J Am Acad Orthop Surg Glob Res 2(3):e088","journal-title":"J Am Acad Orthop Surg Glob Res"},{"issue":"5","key":"5159_CR45","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1136\/annrheumdis-2015-207507","volume":"75","author":"MM Schoels","year":"2016","unstructured":"Schoels MM, Aletaha D, Alasti F, Smolen JS (2016) Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score. Ann Rheum Dis 75(5):811\u2013818","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"5159_CR46","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1136\/annrheumdis-2012-201341","volume":"72","author":"PS Helliwell","year":"2013","unstructured":"Helliwell PS, FitzGerald O, Fransen J, Gladman DD, Kreuger GG, Callis-Duffin K et al (2013) The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann Rheum Dis 72(6):986\u2013991","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"5159_CR47","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1136\/ard.2010.129379","volume":"70","author":"A Mumtaz","year":"2011","unstructured":"Mumtaz A, Gallagher P, Kirby B, Waxman R, Coates LC, Veale JD et al (2011) Development of a preliminary composite disease activity index in psoriatic arthritis. Ann Rheum Dis 70(2):272\u2013277","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"5159_CR48","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00296-017-3887-y","volume":"38","author":"T Georgiev","year":"2018","unstructured":"Georgiev T, Ivanova M, Kopchev A, Velikova T, Miloshov A, Kurteva E et al (2018) Cartilage oligomeric protein, matrix metalloproteinase-3, and Coll2\u20131 as serum biomarkers in knee osteoarthritis: a cross-sectional study. Rheumatol Int 38(5):821\u2013830","journal-title":"Rheumatol Int"},{"issue":"1","key":"5159_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40634-018-0132-x","volume":"5","author":"I Pengas","year":"2018","unstructured":"Pengas I, Eldridge S, Assiotis A, McNicholas M, Mendes JE, Laver L (2018) MMP-3 in the peripheral serum as a biomarker of knee osteoarthritis, 40 years after open total knee meniscectomy. J Exp Orthop 5(1):21","journal-title":"J Exp Orthop"},{"issue":"3","key":"5159_CR50","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jbspin.2012.08.006","volume":"80","author":"F Oliviero","year":"2013","unstructured":"Oliviero F, Scanu A, Galozzi P et al (2013) Prevalence of calcium pyrophosphate and monosodium urate crystals in synovial fluid of patients with previously diagnosed joint diseases. Joint Bone Spine 80(3):287\u2013290","journal-title":"Joint Bone Spine"},{"issue":"3","key":"5159_CR51","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00296-015-3376-0","volume":"36","author":"P Galozzi","year":"2016","unstructured":"Galozzi P, Oliviero F, Frallonardo P et al (2016) The prevalence of monosodium urate and calcium pyrophosphate crystals in synovial fluid from wrist and finger joints. Rheumatol Int 36(3):443\u2013446","journal-title":"Rheumatol Int"},{"issue":"9","key":"5159_CR52","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/jor.20400","volume":"25","author":"MJ Steinbeck","year":"2007","unstructured":"Steinbeck MJ, Nesti LJ, Sharkey PF, Parvizi J (2007) Myeloperoxidase and chlorinated peptides in osteoarthritis: potential biomarkers of the disease. J Orthop Res 25(9):1128\u20131135","journal-title":"J Orthop Res"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05159-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-022-05159-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05159-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T05:03:40Z","timestamp":1659503020000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-022-05159-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,16]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["5159"],"URL":"https:\/\/doi.org\/10.1007\/s00296-022-05159-4","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,16]]},"assertion":[{"value":"10 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no financial or non-financial interests that are directly or indirectly related to this work that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Commission for Scientific Ethics of the Medical University of Plovdiv, Bulgaria-protocol #4, issued on June 10, 2021.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The research involved Human Participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights statement"}},{"value":"Every patient\/participant has written consent to participate.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Every patient\/participant has written consent for publication.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}